#Syndivia

Latest posts tagged with #Syndivia on Bluesky

Trending

#Oscars #Strait of Hormuz #Sonic Racing #Ukraine Conflict #MJF Tribute #Javier Bardem #Marty Supreme #WBC #Andrade #Jessie Buckley #Oscars #Strait of Hormuz #Sonic Racing #Ukraine Conflict #MJF Tribute #Javier Bardem #Marty Supreme #WBC #Andrade #Jessie Buckley

Posts tagged #Syndivia

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

4 months ago

As Blenrep returns, GSK adds another ADC to cancer pipeline GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia.

#GSK #oncology #Blenrep #ADC #antibodydrugconjugates #prostatecancercandidate #Syndivia #advancedcastrationresistantprostatecancer #CRPC #mCRPC #multiplemyeloma #multiplemyelomaADC #prostatecancer #B7H3targetedADC #Hansoh #osteosarcoma #ESMO #GeminiMabconjugationtechnology
zurl.co/8KpGz

0 0 0 0

Chris Tina

@christinahell.bsky.social

4 months ago

Traitement contre le cancer de la prostate : un accord à 300 millions d'euros entre un grand laboratoire pharmaceutique et une société strasbourgeoise Le laboratoire pharmaceutique GSK a révélé avoir acheté les droits exclusifs d'un anticorps conjugué à la société de biotechnologie, Syndivia, lundi 27 octobre. L'entreprise strasbourgeoise a développ...

à la société de biotechnologie, #Syndivia, lundi 27 octobre. L'entreprise strasbourgeoise a développé une technologie permettant de créer des traitements de nouvelle génération contre le cancer de la prostate.)
france3-regions.franceinfo.fr/grand-est/ba...

0 0 0 0

pharmaphorum

@pharmaphorum.bsky.social

4 months ago

As Blenrep returns, GSK adds another ADC to cancer pipeline GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia.

#GSK has boosted its pipeline of #antibodydrugconjugates for cancer, licensing a #prostatecancer candidate from #Syndivia in a deal that could be worth up to £268 million ($358 million).

pharmaphorum.com/news/blenrep...

0 0 0 0